Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-006724
Filing Date
2025-03-07
Accepted
2025-03-07 19:51:39
Documents
2
Period of Report
2025-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3499
2 POWER OF ATTORNEY poa_ltalukdar.htm EX-24 3792
  Complete submission text file 0001437749-25-006724.txt   8673
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1762 BEACON STREET BROOKLINE MA 02445
Business Address
Talukdar Lavina (Reporting) CIK: 0002059193 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39070 | Film No.: 25721795